177 related articles for article (PubMed ID: 8692109)
1. [Immunotherapy of hemato-oncologic diseases].
Winkler U; Bohlen H; Schirrmacher V; Schlimok G; Voliotis D; Brach M; Niederle N; Tesch H; Diehl V; Engert A
Med Klin (Munich); 1996 Apr; 91(4):226-33. PubMed ID: 8692109
[No Abstract] [Full Text] [Related]
2. Cytokine modulation of the innate immune system in the treatment of leukemia and lymphoma.
Farag SS; Caligiuri MA
Adv Pharmacol; 2004; 51():295-318. PubMed ID: 15464915
[No Abstract] [Full Text] [Related]
3. Somatic cell engineering and the immunotherapy of leukemias and lymphomas.
Brentjens RJ; Sadelain M
Adv Pharmacol; 2004; 51():347-70. PubMed ID: 15464917
[No Abstract] [Full Text] [Related]
4. ['94 oncology update].
Pfreundschuh M
Med Klin (Munich); 1995 Mar; 90(3):144-59. PubMed ID: 7723717
[No Abstract] [Full Text] [Related]
5. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy.
Waldmann TA; Dubois S; Tagaya Y
Immunity; 2001 Feb; 14(2):105-10. PubMed ID: 11239443
[No Abstract] [Full Text] [Related]
6. Immunotherapy of cancer.
Salmon SE; Jones SE
Ariz Med; 1977 Jun; 34(6):396-8. PubMed ID: 880051
[No Abstract] [Full Text] [Related]
7. [Immunological approaches to the use of cytokines in the combined treatment of malignant neoplasms].
Kadagidze ZG; Slavina EG
Vopr Onkol; 1995; 41(2):45-6. PubMed ID: 7483430
[No Abstract] [Full Text] [Related]
8. Treatment of childhood malignancies in Kenya.
Kasili EG; Kyambi JM; Onyango JN
East Afr Med J; 1984 Sep; 61(9):663-74. PubMed ID: 6535720
[No Abstract] [Full Text] [Related]
9. [The role of interleukin-2--based immunotherapy in hematological malignancies].
Ackerstein A; Toren A; Slavin S; Nagler A
Harefuah; 1996 May; 130(9):613-7. PubMed ID: 8794642
[No Abstract] [Full Text] [Related]
10. [Pro and con: Immunotherapy in acute leukemia. Arguments for immunotherapy].
Büchner T; Urbanitz D
Internist (Berl); 1980 Jul; 21(7):362-6. PubMed ID: 7007269
[No Abstract] [Full Text] [Related]
11. Heat immunotherapy using magnetic nanoparticles and dendritic cells for T-lymphoma.
Tanaka K; Ito A; Kobayashi T; Kawamura T; Shimada S; Matsumoto K; Saida T; Honda H
J Biosci Bioeng; 2005 Jul; 100(1):112-5. PubMed ID: 16233860
[TBL] [Abstract][Full Text] [Related]
12. Tumour immunotherapy: the adjuvant treatment of the 21st century?
Bremers AJ; Kuppen PJ; Parmiani G
Eur J Surg Oncol; 2000 Jun; 26(4):418-24. PubMed ID: 10873365
[TBL] [Abstract][Full Text] [Related]
13. Is BCG and "orphan" drug suffering from chemotherapists' overkill?
Greenspan EM
Cancer Invest; 1986; 4(1):81-92. PubMed ID: 3513914
[No Abstract] [Full Text] [Related]
14. Childhood cancer: past successes, future directions.
Ferguson WS; Forman EN
Med Health R I; 2002 Jan; 85(1):17-22. PubMed ID: 11824149
[No Abstract] [Full Text] [Related]
15. [Thrombomatch--an ELISA test for detection of antibodies to HLA antigens and platelet-specific antigens. Clinical experiences in compatibility testing of platelet transfusions].
Barz D; Gatzka E; Kollmorgen I
Beitr Infusionsther Transfusionsmed; 1996; 33():47-54. PubMed ID: 8974708
[TBL] [Abstract][Full Text] [Related]
16. Donor lymphocyte infusions.
Ho VT; Alyea EP
Adv Pharmacol; 2004; 51():319-45. PubMed ID: 15464916
[No Abstract] [Full Text] [Related]
17. Vascular attack by 5,6-dimethylxanthenone-4-acetic acid combined with B7.1 (CD80)-mediated immunotherapy overcomes immune resistance and leads to the eradication of large tumors and multiple tumor foci.
Kanwar JR; Kanwar RK; Pandey S; Ching LM; Krissansen GW
Cancer Res; 2001 Mar; 61(5):1948-56. PubMed ID: 11280751
[TBL] [Abstract][Full Text] [Related]
18. [Molecular targeted treatment of hematological diseases with monoclonal antibodies and tyrosine kinase inhibitors. The Danish Society of Hematology].
Geisler CH
Ugeskr Laeger; 2002 Mar; 164(12):1655. PubMed ID: 11924277
[No Abstract] [Full Text] [Related]
19. Non-myeloblative stem-cell transplantation for immunotherapy of cancer and non-malignant diseases with allogeneic lymphocytes.
Slavin S
Isr Med Assoc J; 2002 Apr; 4(4):284-7. PubMed ID: 12001705
[No Abstract] [Full Text] [Related]
20. Reengineered monoclonal antibodies step up to the plate in cancer studies.
Stephenson J
JAMA; 1995 Dec; 274(23):1821-2. PubMed ID: 7500516
[No Abstract] [Full Text] [Related]
[Next] [New Search]
